These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6642726)

  • 1. Middle molecules in the serum, brain, liver and urine of galactosamine-induced fulminant hepatic failure rats.
    Shu CD; Chang TM
    Int J Artif Organs; 1983 Sep; 6(5):273-7. PubMed ID: 6642726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems.
    Dixit V; Chang TM
    ASAIO Trans; 1990; 36(1):21-7. PubMed ID: 2306387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model.
    Dixit V; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):559-73. PubMed ID: 3481555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema.
    Ede RJ; Gove CD; Hughes RD; Marshall W; Williams R
    Clin Sci (Lond); 1987 Mar; 72(3):365-71. PubMed ID: 3028700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins.
    Pappas SC; Ferenci P; Schafer DF; Jones EA
    Gastroenterology; 1984 Mar; 86(3):546-51. PubMed ID: 6693016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An animal model of fulminant hepatic failure in the rat.
    Watanabe A; Higashi T; Nagashima H
    Acta Med Okayama; 1979 Dec; 33(6):443-50. PubMed ID: 161469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of homologous cross-circulation and in situ liver perfusion on fulminant hepatic failure rats.
    Mohsini K; Lister C; Chang TM
    Artif Organs; 1980 Aug; 4(3):171-5. PubMed ID: 7417030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-proliferative effect of plasma from rats with acute fulminant hepatic failure.
    Anilkumar T; Ryan CJ; Aslam M; Poulsom R; Alison M
    Scand J Gastroenterol; 1997 Nov; 32(11):1152-61. PubMed ID: 9399398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma.
    Ryan CJ; Anilkumar T; Ben-Hamida AJ; Khorsandi SE; Aslam M; Pusey CD; Gaylor JD; Courtney JM
    Artif Organs; 2001 Feb; 25(2):109-18. PubMed ID: 11251476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on variation of plasma gamma-aminobutyric acid concentration in rat model of hepatic encephalopathy due to fulminant hepatic failure].
    He X; Luan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):45-8. PubMed ID: 1398623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum, cerebrospinal fluid, and brain levels of bile acids in patients with fulminant hepatic failure.
    Bron B; Waldram R; Silk DB; Williams R
    Gut; 1977 Sep; 18(9):692-6. PubMed ID: 604189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma gamma-aminobutyric acid in experimental fulminant hepatic failure of rats and its diagnostic value in hepatic encephalopathy.
    Wang F; Niu Z; Li ZM
    Chin Med J (Engl); 1990 Mar; 103(3):197-200. PubMed ID: 2114962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid disturbances in experimental hepatic coma rats.
    Shi ZQ; Chang TM
    Int J Artif Organs; 1984 Jul; 7(4):197-202. PubMed ID: 6490191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain methanethiol and ammonia concentrations in experimental hepatic coma and coma induced by injections of various combinations of these substances.
    Zieve L; Doizaki WM; Lyftogt C
    J Lab Clin Med; 1984 Nov; 104(5):655-64. PubMed ID: 6491466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Decreased dopaminergic activity in hepatic encephalopathy in rats with galactosamine-induced acute liver failure].
    Yamada A; Takeuchi H; Miki H; Touge T; Nishioka M
    No To Shinkei; 1992 Feb; 44(2):103-9. PubMed ID: 1567728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of charcoal hemoperfusion on amino acid disturbance in experimental hepatic coma.
    Shi ZQ; Chang TM
    Int J Artif Organs; 1984 Jul; 7(4):203-8. PubMed ID: 6490192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anesthetized model of lethal canine galactosamine fulminant hepatic failure.
    Sielaff TD; Hu MY; Rollins MD; Bloomer JR; Amiot B; Hu WS; Cerra FB
    Hepatology; 1995 Mar; 21(3):796-804. PubMed ID: 7875678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine.
    Hu HL; Chen RD
    Biol Trace Elem Res; 1992 Jul; 34(1):19-25. PubMed ID: 1382518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 15N GC/MS study of in vivo glutamine synthesis in liver failure rats.
    Morishita H; Ukida M; Morimoto Y; Mikami M; Tsuji T
    Acta Med Okayama; 1997 Dec; 51(6):301-4. PubMed ID: 9439771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
    Zeneroli ML
    J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.